ArticleCancers2026

Re-Evaluating Multi-Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Combined Therapy in Colorectal Cancer: A Preclinical Study.

Sergei Boichuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.